Drug Search Results
More Filters [+]

Tilarginine

Alternative Names: tilarginine
Latest Update: 2023-10-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: NOS Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Arginox
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tilarginine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Myocardial Infarction|Shock, Cardiogenic

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

TRIUMPH Study

P3

Completed

Shock, Cardiogenic|Myocardial Infarction

2007-08-22

ARG-CS3-001

P3

Terminated

Myocardial Infarction|Shock, Cardiogenic

None

Recent News Events